March 31, 2026
Novartis must face a False Claims Act suit alleging it improperly had doctors prescribe its multiple sclerosis drug, a New York federal judge said Monday, finding the relator plausibly pled scienter by bringing evidence that the company "kept meticulous track" of how many prescriptions doctors wrote for the drug.
March 31, 2026
Law360 Healthcare Authority looks at appellate arguments from compounding pharmacies alleging they were wrongly barred from making their own versions of weight loss drugs, the Federal Trade Commission's suit over an alleged “rollup” of Texas anesthesiology practices, and other significant litigation developments this week.
October 18, 2023
After a series of startling kickback cases, Novartis Pharmaceuticals on Wednesday contrasted its past misdeeds with newer accusations it bribed prescribers, and Second Circuit judges seemed sympathetic as they pressured a whistleblower's lawyer to substantiate a supposed nationwide scheme.
September 14, 2022
A New York federal judge has tossed a lawsuit accusing Novartis of running a scheme to improperly get doctors to prescribe a multibillion-dollar multiple sclerosis treatment, finding the former employee who brought the suit fell short on proving there was a kickback strategy.